iRhythm Technologies, Inc. (IRTC) Income Statement

NASDAQ: IRTCRevenue, profits, margins and EPS over 10 years.

IRTC 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+26.2%
$747.1M
2025 · hover or tap a bar for each year
2016: $64.1M (+77.3%)2017: $99.1M (+54.7%)2018: $147.3M (+48.6%)2019: $214.6M (+45.7%)2020: $265.2M (+23.6%)2021: $322.8M (+21.7%)2022: $410.9M (+27.3%)2023: $492.7M (+19.9%)2024: $591.8M (+20.1%)2025: $747.1M (+26.2%)
20162025
Gross profit+29.4%
$527.2M
2025 · hover or tap a bar for each year
2016: $43.2M (+101.4%)2017: $70.9M (+64.2%)2018: $108.5M (+53.0%)2019: $162.1M (+49.4%)2020: $194.9M (+20.3%)2021: $213.6M (+9.6%)2022: $281.6M (+31.9%)2023: $331.8M (+17.8%)2024: $407.5M (+22.8%)2025: $527.2M (+29.4%)
20162025
Operating income
−$36.8M
2025 · hover or tap a bar for each year
2016: −$15.6M2017: −$27.6M2018: −$45.7M2019: −$54.8M2020: −$43.7M2021: −$99.9M2022: −$113.8M2023: −$125.2M2024: −$115.5M2025: −$36.8M
20162025
Net income
−$44.6M
2025 · hover or tap a bar for each year
2016: −$20.9M2017: −$29.7M2018: −$50.4M2019: −$54.6M2020: −$43.8M2021: −$101.4M2022: −$116.2M2023: −$123.4M2024: −$113.3M2025: −$44.6M
20162025
EPS (diluted)
−$1.16
2025 · hover or tap a bar for each year
2016: −$3.172017: −$1.302018: −$1.892019: −$2.182020: −$1.592021: −$3.452022: −$2.892023: −$3.582024: −$3.092025: −$1.16
20162025
Net profit margin+13.2 pts
−6.0%
2025 · hover or tap a point for each year
2016: −32.6% (+30.5 pts)2017: −30.0% (+2.6 pts)2018: −34.2% (−4.2 pts)2019: −25.4% (+8.8 pts)2020: −16.5% (+8.9 pts)2021: −31.4% (−14.9 pts)2022: −28.3% (+3.1 pts)2023: −25.0% (+3.2 pts)2024: −19.1% (+5.9 pts)2025: −6.0% (+13.2 pts)
20162025

IRTC revenue and net income

RevenueNet incomeNet margin (right axis)

Where IRTC's revenue goes

2025
Revenue
$747.1M100.0%
Cost of revenue
−$219.9M−29.4%
Gross profit
$527.2M70.6%
Research & development
−$84.6M−11.3%
Sales, general & admin
−$492.6M−65.9%
Other operating expenses
$13.1M1.8%
Operating income
−$36.8M−4.9%
Interest & other expense
−$6.8M−0.9%
Net income
−$44.6M−6.0%

Each bar shows an amount and its share of revenue. IRTC kept −6.0% of revenue as net income.

IRTC profit margins

GrossOperatingNet

IRTC growth rates

to 2025
1 year3 years5 years10 years
Revenue+26.2%+22.1%+23.0%+35.4%
Gross profit+29.4%+23.2%+22.0%+37.7%
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

IRTC quarterly EPS vs estimates

Reported EPSAnalyst estimate

iRhythm beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: October 29, 2026 (estimate $0.02).

IRTC income statement

iRhythm Technologies, Inc. annual income statement
2025202420232022202120202019201820172016
Revenue$747.1M$591.8M$492.7M$410.9M$322.8M$265.2M$214.6M$147.3M$99.1M$64.1M
Cost of revenue$219.9M$184.3M$160.9M$129.3M$109.3M$70.3M$52.5M$38.8M$28.2M$20.9M
Gross profit$527.2M$407.5M$331.8M$281.6M$213.6M$194.9M$162.1M$108.5M$70.9M$43.2M
Research & development$84.6M$103.8M$60.2M$46.6M$38.7M$41.3M$37.3M$20.9M$13.3M$7.2M
Sales, general & admin$492.6M$418.6M$385.6M$322.2M$274.8M$197.2M$179.5M$131.6M$84.7M$51.6M
Total operating expenses$564.1M$523.0M$457.0M$395.4M$313.5M$238.6M$216.8M$154.2M$98.5M$58.8M
Operating income−$36.8M−$115.5M−$125.2M−$113.8M−$99.9M−$43.7M−$54.8M−$45.7M−$27.6M−$15.6M
Interest income$21.5M$21.9M$6.2M$2.0M$118,000—$1.6M$3.1M$3.4M$3.2M
Interest expense$13.2M$12.8M$3.6M$4.1M$1.2M$1.5M$1.6M$3.1M$3.4M$3.2M
Income before taxes−$43.6M−$112.7M−$122.7M−$115.9M−$101.0M−$43.6M−$54.5M−$50.3M−$29.7M−$20.9M
Income taxes$953,000$565,000$750,000$269,000$367,000$229,000$65,000$44,000$3.0M$607,000
Net income−$44.6M−$113.3M−$123.4M−$116.2M−$101.4M−$43.8M−$54.6M−$50.4M−$29.7M−$20.9M
EBITDA−$4.0M−$74.1M−$96.9M−$92.1M−$83.2M−$29.2M−$49.4M−$45.0M−$24.8M−$17.1M
EPS (diluted)−$1.16−$3.09−$3.58−$2.89−$3.45−$1.59−$2.18−$1.89−$1.30−$3.17
Gross margin70.6%68.9%67.3%68.5%66.2%73.5%75.5%73.7%71.5%67.4%
Operating margin−4.9%−19.5%−25.4%−27.7%−31.0%−16.5%−25.5%−31.0%−27.8%−24.3%
Net margin−6.0%−19.1%−25.0%−28.3%−31.4%−16.5%−25.4%−34.2%−30.0%−32.6%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in IRTC's financial statements (latest annual report filed February 19, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

IRTC financial results

In fiscal year 2025 (ended December 31, 2025), iRhythm reported revenue of $747.1 million, up 26.2% from the year before. It had a net loss of $44.6 million, a net profit margin of −6.0%. Diluted earnings per share came to −$1.16. Over five years revenue grew at an average rate of 23.0% a year.

See the IRTC stock overview for the latest quote and news, or the IRTC chart for price history and technical indicators.

IRTC income statement FAQ

What is iRhythm's annual revenue?

iRhythm reported total revenue of $747.1 million for fiscal year 2025, which ended on December 31, 2025. That was up 26.2% from $591.8 million the previous year.

Is iRhythm profitable?

No. iRhythm reported a net loss of $44.6 million in fiscal 2025, a net profit margin of −6.0%; its operating margin was −4.9%.

What is iRhythm's gross margin?

iRhythm's gross margin was 70.6% in fiscal 2025: for every $100 of revenue, iRhythm kept $71 after the direct cost of its products and services.

How much does iRhythm spend on research and development?

iRhythm spent $84.6 million on research and development in fiscal 2025, 11.3% of revenue.

How fast is iRhythm growing?

Revenue grew 23.0% a year on average over the last five fiscal years, from $265.2 million to $747.1 million.

What are iRhythm's earnings per share?

iRhythm earned $-1.16 per diluted share in fiscal 2025, compared with $-3.09 a year earlier.

When will iRhythm report its next earnings?

iRhythm is expected to report results for the quarter ending September 30, 2026 on October 29, 2026.

When does iRhythm's fiscal year end?

iRhythm's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 19, 2026.

Medical Devices income statements